Clinical Trials Directory

Trials / Completed

CompletedNCT04279964

Engaging Practices and Communities in the Development of Interventions to Promote HPV Vaccine Uptake

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2,400 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
9 Years – 26 Years
Healthy volunteers
Not accepted

Summary

The overarching goal of this project is to implement Boot Camp Translation (BCT) methodology to translate the guidelines and evidence for human papillomavirus (HPV) vaccine into a practice and provider level intervention designed to improve its acceptability and uptake.

Detailed description

As a community engagement approach, Boot Camp Translation (BCT), is a 6-9-month iterative process that brings together multiple stakeholders, including patients, parents, and community members, to translate evidence-based guidelines and recommendations into locally relevant and meaningful messages, materials, and programs. Aim 1: Implement BCT in three geographically distinct Colorado communities to translate the current evidence for HPV vaccination into locally relevant interventions designed to increase vaccine uptake. Aim 2: Evaluate the impact of the BCT- designed intervention on practice-level HPV vaccination initiation rates. The long-term goal is to develop a replicable approach and low-cost method of increasing HPV vaccine uptake that is easily adaptable to different settings and sociodemographic contexts.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBoot Camp TranslationPractices in the intervention arm will participate in the Boot Camp Translation process, where BCT Community Advisory group members will come together to develop and implement practice relevant materials to promote adolescent vaccination.
OTHERControlNo intervention. Practices will continue to behave as usual.

Timeline

Start date
2020-05-08
Primary completion
2024-08-31
Completion
2024-08-31
First posted
2020-02-21
Last updated
2025-04-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04279964. Inclusion in this directory is not an endorsement.